1st Quarter - Report

TROUTMAN STRATEGIES for DERMATRAN HEALTH SOLUTIONS LLC

Firm
Client
Income
$20,000
Expenses
—

What was lobbied

One issue area, each in the filer's own words, with who lobbied on it and where.

Pharmacy PHA

Monitor and lobby legislation and regulation relating to compounding pharmacies. Bills include: H.R. 3204, S. 959, and H.R. 3089.

LobbyistCovered position, as disclosed
LINDSAY JORDAN AUSTIN —
ROBERT LEEBERN —
TOM TILTON —

Contacted: Food & Drug Administration (FDA); SENATE; Defense, Dept of (DOD); Veterans Affairs, Dept of (VA); HOUSE OF REPRESENTATIVES

Bills named: H.R. 3089 (113th), H.R. 3204 (113th), S. 959 (113th)

Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.